Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.15
Delayed Data
As of 3:59pm ET
 -0.09 / -1.72%
Today’s Change
2.60
Today|||52-Week Range
9.25
-18.64%
Year-to-Date

Today’s Trading

Previous close5.24
Today’s open5.29
Day’s range5.11 - 5.34
Volume1,026,715
Average volume (3 months)1,551,615
Market cap$421.4M
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+2.37%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book244.97

Competitors

 Today’s
change
Today’s
% change
BOLDAudentes Therapeutic...+0.26+1.54%
IMGNImmunoGen Inc-0.18-3.49%
GERNGeron Corp+0.03+0.98%
ATRAAtara Biotherapeutic...+0.15+0.99%
Data as of 3:59pm ET, 05/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts